We use cookies for a better user experience. Read our Privacy Policy

I Agree

Orthobiologics Market

Orthobiologics Market (Product: Bone Morphogenetic Proteins, Demineralized Bone Matrix, Synthetic Bone Substitutes, Viscosupplements, Allografts, and Stem Cell) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Global Orthobiologics Market Outlook 2031

  • The global orthobiologics market was valued at US$ 5.01 Bn in 2021
  • The global market is projected to grow at a CAGR of 4.7% from 2022 to 2031
  • The global orthobiologics market is anticipated to reach more than US$ 7.4 Bn by the end of 2031

Analysts’ Viewpoint on Orthobiologics Market Scenario

Orthobiologics are being regularly used in orthopedic surgeries and sports medicines since the last few years. The global orthobiologics market is likely to be driven by the rise in rate of sports injuries, ongoing influx of new products & treatment options, advancements in the field of regenerative medicine, and growth in demand for minimally invasive surgeries. However, the COVID-19 pandemic has led to a slowdown in research in the fields of musculoskeletal tissue engineering and regenerative medicine. Nevertheless, high growth potential in emerging countries and increase in demand for advanced treatments are projected to present significant opportunities for orthobiologics companies during the forecast period.

orthobiologics market

Overview of Global Orthobiologics Market

Orthobiologics encompass a broad range of technologies with a biological or biochemical component. Examples include biologic factors delivered through a device, bone graft materials, cell therapies, and resorbable scaffolds to reinforce soft tissue. Rise in usage of orthobiologics products and orthopedic devices, and the integration of biology and biochemistry in the treatment of bone and soft tissue injuries are driving the orthobiologics market. Orthobiologics are medications that speed up the body's natural healing process. They can help repair osteoarthritis damage as well as accelerate the recovery of strained muscles, tendons, and ligaments. Orthobiologics are made with components that are naturally found in the human body. Rise in prevalence of inflammatory conditions such as osteoarthritis and tendinitis along with increase in participation in a sports activity that can lead to ligament or muscle injury in teenagers and young adults is expected to drive the global orthobiologics market during the forecast period. Orthobiologics, which has the potential to accelerate the healing process for pain and injuries, provides solutions and hope for people who want to live a pain-free life.

Request a sample to get extensive insights into the Orthobiologics Market

Surge in Sports Injuries to Drive Global Orthobiologics Market

Sports injuries have become a major concern for athletes. The musculoskeletal system, which consists of the muscles, tendons, ligaments, fascia, nerves, bones, and tissues, is involved in sports injuries. Falls, excessive exertion, and fractures are the primary causes of these injuries. Lower and upper extremities suffer the majority of sports-related injuries and muscle injuries. Orthobiologics, such as stem cells, are used to treat common, acute, and chronic sports injuries. Year-round participation in a single sport is the most significant cause of increase in youth injuries. Rugby, combat sports, field hockey, basketball, and handball account for the most number of hand injuries.

In the last few decades, there has been an increase in sports participation by children and adolescents at an early age in the U.S. There has also been a rise in specialization in sports at a very early age. This trend has contributed to the patterns of injuries seen in young athletes. Injuries previously observed in mature athletes are now being reported in young athletes. According to a study published by the National Library of Medicine, 3.5 million youth under the age of 15 receive medical care each year in the U.S. for injuries sustained during sports practice.

Increase in Demand for Non-surgical Treatments for Osteoarthritis to Propel Viscosupplements Segment

In terms of product, the viscosupplements segment held significant market share in 2021. Increase in demand for non-surgical treatments for osteoarthritis, rise in prevalence of lifestyle-induced disorders, and advancements in hyaluronic acid-based therapies are expected to drive the viscosupplements segment during the forecast period. Viscosupplements demonstrate clinical efficacy and is the most effective treatment for knee osteoarthritis. Osteoarthritis is the most common joint disorder in the U.S., affecting nearly 27 million people. Osteoarthritis of the knee alone affects 10% of men and 13% of women over the age of 60. Viscosupplementation can significantly reduce pain while improving joint mobility and function, making daily activities and even athletic or strenuous exercise less painful. Manufacturers of viscosupplementation devices are striving to develop and get approval for new medicines to treat osteoarthritis of the elbow, hip, and knee.

Request a custom report on Orthobiologics Market

Rise in Number of Spinal and Sports-related Injuries to Boost Demand for Spinal Fusion Devices

The spinal fusion segment accounted for the largest share of the global orthobiologics market in 2021. The segment is expected to be driven by the increase in number of spinal injuries and sports-related injuries during the forecast period. Demand for spinal fusion devices has been rising across the globe. Majority of spinal cord injuries are caused by avoidable incidences such as car accidents, falls, or violence. Traumatic spinal injury (TSI) occurs when bony, ligamentous, and/or neurologic structures of the spinal column are injured and result in significant morbidity and mortality.

Provision of Majority of Orthopedic Surgeries to Drive Hospitals Segment

In terms of end-user, the hospitals segment is projected to account for a major share of the global orthobiologics market during the forecast period. Orthopedic surgery is performed in hospitals on various parts such as the shoulder, ankle, hip, knee, wrists, elbow, and spine, depending on the type of injury or damage. Knee joint replacement, arthroscopy, pediatric orthopedic, and other minimally invasive orthopedic surgeries are the most commonly recommended procedures. Hence, the hospitals segment is likely to capture significant market share during the forecast period. Surgeries were traditionally performed in hospitals; however, advances in technology, anesthesia, and pain control now allow physicians to perform certain procedures in an orthopedic clinic center. This is projected to drive the orthopedic clinics segment in the next few years.

Regional Outlook of Global Orthobiologics Market

North America accounted for the largest share of around 45% of the global orthobiologics market in 2021. It is projected to be a highly lucrative region of the global market during the forecast period. Increase in demand for orthobiologics products, highly developed healthcare system, and availability of advanced therapy for orthopedic treatment are the factors driving the market in North America. The U.S. dominated the market in North America in 2021 due to the significant increase in spine injuries caused by falls and accidents in the country. According to the Department of Health and Human Services, two million people in the country suffer from sports-related injuries every year. There is also a greater understanding of orthobiologics and its benefits, such as accelerated healing capabilities, faster recoveries, and fewer hospital visits.

The market in Asia Pacific is expected to grow at a rapid pace during the forecast period. Rise in geriatric and target patient population, high incidence of osteoarthritis and obesity, increase in government healthcare spending, and improved healthcare infrastructure are the major factors driving the market in the region. Furthermore, Asia Pacific was the leading market for non-industry-sponsored osteoarthritis trials, accounting for a significant share in 2021.

Analysis of Key Players in Global Orthobiologics Market

The global orthobiologics market is consolidated, with the presence of small number of leading players. Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by the leading players in the global orthobiologics market. Alphatec Spine, Inc., Integra Life Sciences, DePuy Synthes, Seikagaku Corporation, Arthrex, RTI Surgical, Inc., MTF Biologics, Exactech, Inc., Johnson & Johnson, Sanofi, and Stryker are the prominent players operating in the global orthobiologics market.

Key Developments in Global Orthobiologics Market

  • In March 2022, MTF Biologics and Orthofix Medical, Inc. extended their orthobiologics collaboration. The agreement extends Orthofix's exclusive marketing rights to the Trinity allograft line till 2032 and includes an expansion agreement for the development of a demineralized bone matrix (DBM) that Orthofix will market under the Legacy brand name.
  • In November 2020, OssDsign expanded into the large and rapidly growing orthobiologics segment, thereby taking the first transformative step toward becoming a broader orthopedic player. OssDsign expanded its product portfolio with the addition of a next-generation nanosynthetic bone graft substitute designed to treat skeletal defects.
  • In March 2016, Zimmer Biomet entered into an exclusive global distribution agreement with recently formed upstart CelgenTek Innovations to distribute its fracture fixation system and a bone-void filler

Each of these players has been profiled in the orthobiologics market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Orthobiologics Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 5.01 Bn

Market Forecast Value in 2031

More than US$ 7.4 Bn

Growth Rate

(CAGR)

4.7%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Bone Morphogenetic Proteins
    • Demineralized Bone Matrix
    • Synthetic Bone Substitutes
    • Viscosupplements
    • Allografts
    • Stem cell
    • Others
  • Application
    • Spinal Fusion
    • Trauma Repair
    • Reconstructive Surgeries
    • Others
  • End-user
    • Hospitals
    • Orthopedic Clinics
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries

Companies Profiled

  • Alphatec Spine, Inc.
  • Arthrex
  • Bioventus
  • DePuy Synthes
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Integra Life Sciences
  • Johnson & Johnson
  • Medtronic plc
  • MTF Biologics
  • RTI Surgical, Inc.
  • Sanofi
  • Stryker
  • Zimmer Biomet

Customization Scope

Available upon request

Pricing

Available upon request

Orthobiologics Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global orthobiologics market in 2021?

The global orthobiologics market was valued at US$ 5.01 Bn in 2021.

How big will be the global orthobiologics market in 2031?

The global orthobiologics market is projected to reach more than US$ 7.4 Bn by 2031.

What will be the CAGR of the global orthobiologics market during the forecast period (2022–2031)?

The global orthobiologics market is anticipated to grow at a CAGR of 4.7% from 2022 to 2031.

Which are the prominent trends that affect market growth?

Increase in incidence of sports injuries and road accidents is driving the global orthobiologics market.

Which region will account for major share of the global market during the forecast period?

North America is expected to account for major share of the global market during the forecast period.

Who are the prominent players in the global orthobiologics market?

Prominent players in the global orthobiologics market include Alphatec Spine, Inc., Integra Life Sciences, DePuy Synthes, Seikagaku Corporation, Arthrex, RTI Surgical, Inc., MTF Biologics, Exactech, Inc., Johnson & Johnson, Integra Life Sciences, Sanofi, and Stryker.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Orthobiologics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Orthobiologics Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Key Market Trends

    5.2. Merger and Acquisition

    5.3. Strategies of Top Five Players Operating in the Market

    5.4. Incidence of Orthopedic Disorder, by Key Countries

    5.5. Regulatory and Reimbursement Scenario, by Key Countries

6. Global Orthobiologics Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Market Value Forecast, by Product, 2017–2031

        6.2.1. Demineralized Bone Matrix

        6.2.2. Allografts

        6.2.3. Synthetic Bone Substitutes

        6.2.4. Viscosupplements

        6.2.5. Bone Morphogenetic Proteins

        6.2.6. Stem Cell Therapy

        6.2.7. Others

    6.3. Market Attractiveness, by Product

7. Global Orthobiologics Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Market Value Forecast, by Application, 2017–2031

        7.2.1. Spinal Fusion

        7.2.2. Trauma Repair

        7.2.3. Reconstructive Surgeries

        7.2.4. Others

    7.3. Market Attractiveness Analysis, by Application

8. Global Orthobiologics Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Market Value Forecast, by End-user, 2017–2031

        8.2.1. Hospitals

        8.2.2. Orthopedic Clinics

        8.2.3. Others

    8.3. Market Attractiveness Analysis, by End-user

9. Global Orthobiologics Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Orthobiologics Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017–2031

        10.2.1. Demineralized Bone Matrix

        10.2.2. Allografts

        10.2.3. Synthetic Bone Substitutes

        10.2.4. Viscosupplements

        10.2.5. Bone Morphogenetic Proteins

        10.2.6. Stem Cell Therapy

        10.2.7. Others

    10.3. Market Value Forecast, by Application, 2017–2031

        10.3.1. Spinal Fusion

        10.3.2. Trauma Repair

        10.3.3. Reconstructive Surgeries

        10.3.4. Others

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Hospitals

        10.4.2. Orthopedic Clinics

        10.4.3. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Orthobiologics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2031

        11.2.1. Demineralized Bone Matrix

        11.2.2. Allografts

        11.2.3. Synthetic Bone Substitutes

        11.2.4. Viscosupplements

        11.2.5. Bone Morphogenetic Proteins

        11.2.6. Stem Cell Therapy

        11.2.7. Others

    11.3. Market Value Forecast, by Application, 2017–2031

        11.3.1. Spinal Fusion

        11.3.2. Trauma Repair

        11.3.3. Reconstructive Surgeries

        11.3.4. Others

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Hospitals

        11.4.2. Orthopedic Clinics

        11.4.3. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Orthobiologics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2031

        12.2.1. Demineralized Bone Matrix

        12.2.2. Allografts

        12.2.3. Synthetic Bone Substitutes

        12.2.4. Viscosupplements

        12.2.5. Bone Morphogenetic Proteins

        12.2.6. Stem Cell Therapy

        12.2.7. Others

    12.3. Market Value Forecast, by Application, 2017–2031

        12.3.1. Spinal Fusion

        12.3.2. Trauma Repair

        12.3.3. Reconstructive Surgeries

        12.3.4. Others

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Hospitals

        12.4.2. Orthopedic Clinics

        12.4.3. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Orthobiologics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2031

        13.2.1. Demineralized Bone Matrix

        13.2.2. Allografts

        13.2.3. Synthetic Bone Substitutes

        13.2.4. Viscosupplements

        13.2.5. Bone Morphogenetic Proteins

        13.2.6. Stem Cell Therapy

        13.2.7. Others

    13.3. Market Value Forecast, by Application, 2017–2031

        13.3.1. Spinal Fusion

        13.3.2. Trauma Repair

        13.3.3. Reconstructive Surgeries

        13.3.4. Others

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Hospitals

        13.4.2. Orthopedic Clinics

        13.4.3. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Orthobiologics Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product, 2017–2031

        14.2.1. Demineralized Bone Matrix

        14.2.2. Allografts

        14.2.3. Synthetic Bone Substitutes

        14.2.4. Viscosupplements

        14.2.5. Bone Morphogenetic Proteins

        14.2.6. Stem Cell Therapy

        14.2.7. Others

    14.3. Market Value Forecast, by Application, 2017–2031

        14.3.1. Spinal Fusion

        14.3.2. Trauma Repair

        14.3.3. Reconstructive Surgeries

        14.3.4. Others

    14.4. Market Value Forecast, by End-user, 2017–2031

        14.4.1. Hospitals

        14.4.2. Orthopedic Clinics;

        14.4.3. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Product

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competitive Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company (2021)

    15.3. Company Profiles

        15.3.1. Medtronic

            15.3.1.1. Company Overview

            15.3.1.2. Product Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Financial Overview

            15.3.1.5. Strategic Overview

        15.3.2. DePuy Synthes  (Johnson & Johnson)

            15.3.2.1. Company Overview

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Financial Overview

            15.3.2.5. Strategic Overview

        15.3.3. Sanofi

            15.3.3.1. Company Overview

            15.3.3.2. Product Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Financial Overview

            15.3.3.5. Strategic Overview

        15.3.4. Seikagaku Corporation

            15.3.4.1. Company Overview

            15.3.4.2. Product Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Financial Overview

            15.3.4.5. Strategic Overview

        15.3.5. Stryker

            15.3.5.1. Company Overview

            15.3.5.2. Product Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Financial Overview

            15.3.5.5. Strategic Overview

        15.3.6. MTF Biologics

            15.3.6.1. Company Overview

            15.3.6.2. Product Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Financial Overview

            15.3.6.5. Strategic Overview

        15.3.7. Bioventus LLC

            15.3.7.1. Company Overview

            15.3.7.2. Product Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Financial Overview

            15.3.7.5. Strategic Overview

        15.3.8. Arthrex

            15.3.8.1. Company Overview

            15.3.8.2. Product Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Financial Overview

            15.3.8.5. Strategic Overview

        15.3.9. Zimmer Biomet

            15.3.9.1. Company Overview

            15.3.9.2. Product Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Financial Overview

            15.3.9.5. Strategic Overview

        15.3.10. RTI Surgical, Inc.

            15.3.10.1. Company Overview

            15.3.10.2. Product Portfolio

            15.3.10.3. SWOT Analysis

            15.3.10.4. Financial Overview

            15.3.10.5. Strategic Overview

        15.3.11. Alphatec Spine, Inc.

            15.3.11.1. Company Overview

            15.3.11.2. Product Portfolio

            15.3.11.3. SWOT Analysis

            15.3.11.4. Financial Overview

            15.3.11.5. Strategic Overview

        15.3.12. Exactech, Inc.

            15.3.12.1. Company Overview

            15.3.12.2. Product Portfolio

            15.3.12.3. SWOT Analysis

            15.3.12.4. Financial Overview

            15.3.12.5. Strategic Overview

        15.3.13. Globus Medical, Inc.

            15.3.13.1. Company Overview

            15.3.13.2. Product Portfolio

            15.3.13.3. SWOT Analysis

            15.3.13.4. Financial Overview

            15.3.13.5. Strategic Overview

        15.3.14. Integra LifeSciences

            15.3.14.1. Company Overview

            15.3.14.2. Product Portfolio

            15.3.14.3. SWOT Analysis

            15.3.14.4. Financial Overview

            15.3.14.5. Strategic Overview

List of Tables

Table 01: Global Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Orthobiologics Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Orthobiologics Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 07: North America Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 08: North America Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 11: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 12: Europe Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 16: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 19: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 20: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 23: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 24: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Orthobiologics Market Size (US$ Mn) and Distribution (%), by Region, 2018 and 2031

Figure 02: Global Orthobiologics Market Revenue (US$ Mn), by Product, 2021

Figure 03: Global Orthobiologics Market Value Share, by Product, 2021

Figure 04: Global Orthobiologics Market Value Share, by Application, 2021

Figure 05: Global Orthobiologics Market Value Share, by End-user, 2021

Figure 06: Global Orthobiologics Market Value Share, by Region, 2021

Figure 07: Global Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031

Figure 08: Global Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031

Figure 09: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bone Morphogenetic Proteins, 2017–2031

Figure 10: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Demineralized Bone Matrix, 2017–2031

Figure 11: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Synthetic Bone Substitutes, 2017–2031

Figure 12: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Viscosupplements, 2017–2031

Figure 13: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Allografts, 2017–2031

Figure 14: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stem Cell, 2017–2031

Figure 15: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031

Figure 16: Global Orthobiologics Market Attractiveness Analysis, by Product, 2022-2031

Figure 17: Global Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031

Figure 18: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Spinal Fusion, 2017–2031

Figure 19: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Trauma Repair, 2017–2031

Figure 20: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Restorative Surgery, 2017–2031

Figure 21: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031

Figure 22: Global Orthobiologics Market Attractiveness Analysis, by Application, 2022-2031

Figure 23: Global Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031

Figure 24: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2031

Figure 25: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Orthopedic Clinics, 2017–2031

Figure 26: Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031

Figure 27: Global Orthobiologics Market Attractiveness Analysis, by End-user, 2022-2031

Figure 28: Global Orthobiologics Market Value Share Analysis, by Region, 2017 and 2031

Figure 29: Global Orthobiologics Market Attractiveness Analysis, by Region, 2022-2031

Figure 30: North America Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 31: North America Orthobiologics Market Attractiveness Analysis, by Country, 2017–2031

Figure 32: North America Orthobiologics Market Value Share Analysis, by Country, 2017 and 2031

Figure 33: North America Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031

Figure 34: North America Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031

Figure 35: North America Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031

Figure 36: North America Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031

Figure 37: North America Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031

Figure 38:North America Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031

Figure 39: Europe Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 40: Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 41: Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2031

Figure 42: Europe Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031

Figure 43: Europe Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031

Figure 44: Europe Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031

Figure 45: Europe Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031

Figure 46: Europe Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031

Figure 47: Europe Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031

Figure 48: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 49: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 50: Asia Pacific Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2031

Figure 51: Asia Pacific Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031

Figure 52: Asia Pacific Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031

Figure 53: Asia Pacific Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031

Figure 54: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031

Figure 55: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031

Figure 56: Asia Pacific Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031

Figure 57: Latin America Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 58: Latin America Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 59: Latin America Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2031

Figure 60: Latin America Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031

Figure 61: Latin America Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031

Figure 62: Latin America Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031

Figure 63: Latin America Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031

Figure 64: Latin America Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031

Figure 65: Latin America Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031

Figure 66: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 67: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 68: Middle East & Africa Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2031

Figure 69: Middle East & Africa Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031

Figure 70: Middle East & Africa Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031

Figure 71: Middle East & Africa Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031

Figure 72: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031

Figure 73: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031

Figure 74: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

623

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved